Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • heah
    Junior Member
    • May 2013
    • 3

    #1

    SeqGSEA: High p-value, low FDR

    Hello!

    I'm running SeqGSEA with 1000 permutations and the enriched gene sets have high p-values (lowest is 0.105) and low FDRs. Does this make sense? Shouldn't FDR be always higher than the corresponding p-value? Also, many of the p-values are the same.

    I get these warnings when running the analysis:
    4: In .local(object, ...) :
    in estimateDispersions: sharingMode=='gene-est-only' will cause inflated numbers of false positives unless you have many replicates.
    5: In parametricDispersionFit(means, disps) :
    Dispersion fit did not converge.

    Here's a sample output:

    GSName GSSize ES ES.pos pval FDR FWER
    GSE10325 168 1.22808662 5130 0.105 0 0.499
    GSE12366 179 1.309364504 3994 0.105 0 0.391
    GSE20366 168 1.245278455 4337 0.105 0 0.391
    GSE22886 141 1.23398734 4313 0.105 0 0.499
    GSE22886 176 1.244872228 3485 0.105 0 0.391
    GSE24634 161 1.231951927 1188 0.105 0 0.499
    GSE27786 186 1.231516643 2291 0.105 0 0.499
    GSE39820 175 1.236275596 2472 0.105 0 0.499
    GSE39820 174 1.250791386 3043 0.105 0 0.391
    GSE17721 173 1.190668483 4093 0.105 0.0125 0.711
    GSE3982 161 1.191279385 6536 0.105 0.012658 0.711
    GSE3982 164 1.193291389 2810 0.105 0.012987 0.711
    GSE7460 151 1.193674617 5536 0.105 0.013158 0.604
    GSE360 154 1.195713581 4812 0.105 0.013514 0.604
    GSE8515 168 1.195932546 2346 0.105 0.013699 0.604
    GSE2197 167 1.197065779 5368 0.105 0.014286 0.604
    GSE3982 169 1.201872999 1001 0.105 0.015625 0.604

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...